Publicacións en colaboración con investigadores/as de Pontifícia Universidade Católica do Rio Grande do Sul (5)

2024

  1. Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA

    Annals of Oncology, Vol. 35, Núm. 9, pp. 805-816

  2. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

2022

  1. Erratum to: Is Sensory Loss an Understudied Risk Factor for Frailty? A Systematic Review and Meta-analysis

    The journals of gerontology. Series A, Biological sciences and medical sciences

2020

  1. Is Sensory Loss an Understudied Risk Factor for Frailty? A Systematic Review and Meta-analysis

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 75, Núm. 12, pp. 2461-2470

  2. Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 38, Núm. 3, pp. 203-213